Heterotopic thyroid autotransplantation: A preliminary clinical study

Head Neck. 2018 Jan;40(1):34-45. doi: 10.1002/hed.24904. Epub 2017 Oct 27.

Abstract

Background: Thyroid autotransplantation offers an attractive alternative to subtotal thyroidectomy and replacement therapy. However, it has not been sufficiently clinically investigated.

Methods: Total thyroidectomy was performed for 20 patients with benign thyroid disorders, and at least 10 g of thyroid tissue were implanted intramuscularly. Graft monitoring was achieved through 99m Tc scan at 2 months, free triiodothyronine (FT3), FT4, and thyroid-stimulating hormone (TSH) measurements at 1, 2, 4, 6, 8, 10, and 12 months postoperatively, and clinical examination.

Results: Grafts survived and gradually functioned in all patients to a variable extent after a latent period (mean 99m Tc uptake = 1.28 ± 0.37%). Mean values for FT3, FT4, TSH at 12 months were 1.75 ± 0.48 pg/mL, 1.06 ± 0.26 ng/dL, and 28.08 ± 34.01 μIU/mL respectively.

Conclusion: Thyroid autotransplantation restored euthyroid status in 33.3% of patients after 12 months. A role of age, operative time, and 99m Tc-uptake in determining the final graft outcome is possible.

Keywords: autotransplantation; graft; heterotopic; thyroid; total thyroidectomy.

MeSH terms

  • Adult
  • Biopsy, Fine-Needle
  • Chi-Square Distribution
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Hypothyroidism / prevention & control*
  • Injections, Intramuscular
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Patient Selection
  • Radionuclide Imaging / methods
  • Retrospective Studies
  • Risk Assessment
  • Thyroid Diseases / pathology
  • Thyroid Diseases / surgery*
  • Thyroid Gland / transplantation*
  • Thyroidectomy / methods*
  • Tissue and Organ Harvesting / methods
  • Transplantation, Autologous / methods
  • Treatment Outcome